88 results
Page 4 of 5
8-K
EX-99.2
oieic
16 Oct 15
Regulation FD Disclosure
12:00am
424B5
ueb6jb
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
cti wy9maqipqd1ri5
9 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
aptnk3 butvk2f89t
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.2
138za97n
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.1
ripquxdwjmydg88i4je
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.1
pcqo1zx826tf
19 Nov 14
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120
12:00am
8-K
EX-99.1
v62ip lyzb1hq
7 Nov 14
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
uzhmo
15 Oct 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
jb3rsgi19 2ch91ofmrx
7 Aug 14
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
12:00am